Metropolitan Life Insurance CO Reata Pharmaceuticals Inc Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

48 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023
BUY
$79.22 - $105.37 $5,228 - $6,954
66 Added 4.41%
1,561 $159,000
Q1 2023

May 15, 2023
SELL
$30.85 - $93.17 $8,946 - $27,019
-290 Reduced 16.25%
1,495 $135,000
Q4 2022

Jun 14, 2023
BUY
$22.15 - $42.11 $6,423 - $12,211
290 Added 19.4%
1,785 $67.8 Million
Q3 2022

Jun 14, 2023
BUY
$19.41 - $36.49 $5,628 - $10,582
290 Added 19.4%
1,785 $44.9 Million
Q2 2022

Jun 20, 2023
BUY
$20.71 - $36.5 $6,005 - $10,585
290 Added 19.4%
1,785 $54,000
Q1 2022

Jun 20, 2023
BUY
$24.12 - $39.6 $6,994 - $11,484
290 Added 19.4%
1,785 $58,000
Q1 2022

Mar 30, 2023
SELL
$24.12 - $39.6 $138,786 - $227,858
-5,754 Reduced 76.32%
1,785 $58,000
Q1 2022

May 12, 2022
SELL
$24.12 - $39.6 $138,786 - $227,858
-5,754 Reduced 76.32%
1,785 $58,000
Q4 2021

Jun 21, 2023
BUY
$25.61 - $110.96 $154,786 - $670,642
6,044 Added 404.28%
7,539 $198,000
Q3 2021

Jun 21, 2023
BUY
$100.0 - $143.02 $604,400 - $864,412
6,044 Added 404.28%
7,539 $758,000
Q3 2021

Mar 30, 2023
BUY
$100.0 - $143.02 $800 - $1,144
8 Added 0.11%
7,539 $758,000
Q3 2021

Nov 15, 2021
BUY
$100.0 - $143.02 $800 - $1,144
8 Added 0.11%
7,539 $758,000
Q2 2021

Jun 21, 2023
BUY
$78.27 - $151.29 $472,437 - $913,186
6,036 Added 403.75%
7,531 $1.07 Million
Q2 2021

Mar 30, 2023
BUY
$78.27 - $151.29 $456,314 - $882,020
5,830 Added 342.74%
7,531 $1.07 Million
Q2 2021

Aug 16, 2021
BUY
$78.27 - $151.29 $589,294 - $1.14 Million
7,529 Added 376450.0%
7,531 $1.07 Million
Q1 2021

Jun 26, 2023
BUY
$94.25 - $132.81 $24,599 - $34,663
261 Added 17.46%
1,756 $175 Million
Q1 2021

Mar 30, 2023
BUY
$94.25 - $132.81 $1,790 - $2,523
19 Added 1.13%
1,701 $169,000
Q1 2021

May 14, 2021
SELL
$94.25 - $132.81 $158,340 - $223,120
-1,680 Reduced 99.88%
2 $170,000
Q4 2020

Jun 22, 2023
BUY
$102.03 - $184.62 $19,079 - $34,523
187 Added 12.51%
1,682 $207,000
Q4 2020

Mar 30, 2023
SELL
$102.03 - $184.62 $3,366 - $6,092
-33 Reduced 1.92%
1,682 $207,000
Q4 2020

Feb 16, 2021
SELL
$102.03 - $184.62 $3,366 - $6,092
-33 Reduced 1.92%
1,682 $208,000
Q3 2020

Jun 26, 2023
BUY
$93.53 - $163.34 $20,576 - $35,934
220 Added 14.72%
1,715 $167,000
Q3 2020

Mar 30, 2023
SELL
$93.53 - $163.34 $1,964 - $3,430
-21 Reduced 1.21%
1,715 $167,000
Q3 2020

Nov 13, 2020
SELL
$93.53 - $163.34 $1,964 - $3,430
-21 Reduced 1.21%
1,715 $167,000
Q2 2020

Jun 26, 2023
BUY
$126.3 - $176.56 $30,438 - $42,550
241 Added 16.12%
1,736 $270,000
Q2 2020

Mar 30, 2023
SELL
$126.3 - $176.56 $644,887 - $901,515
-5,106 Reduced 74.63%
1,736 $270,000
Q2 2020

Aug 14, 2020
SELL
$126.3 - $176.56 $644,887 - $901,515
-5,106 Reduced 74.63%
1,736 $271,000
Q1 2020

Jul 12, 2023
BUY
$124.16 - $247.74 $668,601 - $1.33 Million
5,385 Added 360.2%
6,880 $993,000
Q1 2020

Mar 30, 2023
BUY
$124.16 - $247.74 $4,221 - $8,423
34 Added 0.5%
6,842 $987,000
Q1 2020

May 15, 2020
BUY
$124.16 - $247.74 $4,221 - $8,423
34 Added 0.5%
6,842 $988,000
Q4 2019

Jul 12, 2023
BUY
$74.57 - $217.92 $396,190 - $1.16 Million
5,313 Added 355.38%
6,808 $1.39 Million
Q4 2019

Mar 30, 2023
BUY
$74.57 - $217.92 $15,585 - $45,545
209 Added 3.17%
6,808 $1.39 Million
Q4 2019

Feb 14, 2020
BUY
$74.57 - $217.92 $15,585 - $45,545
209 Added 3.17%
6,808 $1.39 Million
Q3 2019

Jul 12, 2023
BUY
$71.26 - $95.75 $363,711 - $488,708
5,104 Added 341.4%
6,599 $529,000
Q3 2019

Mar 30, 2023
BUY
$71.26 - $95.75 $37,625 - $50,556
528 Added 8.7%
6,599 $529,000
Q3 2019

Nov 14, 2019
BUY
$71.26 - $95.75 $37,625 - $50,556
528 Added 8.7%
6,599 $530,000
Q2 2019

Jul 12, 2023
BUY
$77.72 - $94.35 $364,118 - $442,029
4,685 Added 313.38%
6,180 $583,000
Q1 2019

Jul 13, 2023
BUY
$51.9 - $101.79 $237,494 - $465,791
4,576 Added 306.09%
6,071 $518,000
Q1 2019

Mar 30, 2023
BUY
$51.9 - $101.79 $222,443 - $436,271
4,286 Added 240.11%
6,071 $518,000
Q1 2019

May 16, 2019
SELL
$51.9 - $101.79 $945,099 - $1.85 Million
-18,210 Reduced 75.0%
6,071 $518,000
Q1 2019

May 15, 2019
BUY
$51.9 - $101.79 $945,099 - $1.85 Million
18,210 Added 299.95%
24,281 $621,000
Q4 2018

Jul 13, 2023
BUY
$48.76 - $76.44 $223,125 - $349,789
4,576 Added 306.09%
6,071 $340,000
Q4 2018

Feb 14, 2019
BUY
$48.76 - $76.44 $231,171 - $362,402
4,741 Added 356.47%
6,071 $341,000
Q3 2018

Jul 13, 2023
BUY
$35.64 - $92.06 $163,088 - $421,266
4,576 Added 306.09%
6,071 $496 Million
Q3 2018

Nov 14, 2018
SELL
$35.64 - $92.06 $147,193 - $380,207
-4,130 Reduced 75.64%
1,330 $109,000
Q2 2018

Aug 15, 2018
BUY
$19.94 - $40.96 $37,826 - $77,701
1,897 Added 53.24%
5,460 $0
Q4 2017

Feb 15, 2018
SELL
$22.39 - $33.27 $65,580 - $97,447
-2,929 Reduced 45.12%
3,563 $101,000
Q2 2017

Aug 14, 2017
BUY
N/A
6,492
6,492 $205,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email